A London team at Covington & Burling led by corporate partner Lucinda Osborne advised AstraZeneca on a potential $2.1bn deal to purchase Spanish healthcare group Almirall’s respiratory unit in a move that sees the company add to its pipeline of asthma products.
Continue reading “Covington and CMS lead on AstraZeneca’s £1.2bn Spanish transaction”
